![\"2009-02-16-more-d-research-copy.jpg\"](\"https:\/\/smarttan.com\/blog\/wp-content\/uploads\/2009\/02\/2009-02-16-more-d-research-copy.thumbnail.jpg\")
<\/a>The study\u2019s findings, reported in June 2007, showed for the first time in a clinical trial that postmenopausal women consuming calcium as well as vitamin D3 supplements at nearly three times U.S. government recommended levels could reduce their risk of cancer by 60-77 percent.<\/p>\nThe vitamin D3 finding was a secondary goal in the original study,\u201d said Creighton researcher Joan Lappe, Ph.D. \u201cWe must now confirm these findings with a clinical trial specifically designed to look at calcium, vitamin D and cancer. Confirmation is necessary in order to have evidence solid enough to change public policy regarding intake levels for vitamin D.\u201d<\/p>\n
Most vitamin D researchers are already calling for people to increase their vitamin D levels to 40-60 ng\/ml as measured in blood concentration, recognizing that different intake levels will be necessary for different people to obtain those blood levels. Outdoor workers and non-human primates living in sunny climates, groups who make abundant vitamin D naturally through sun exposure to the skin, already have those levels.<\/p>\n
Lappe, holder of the Dr. C.C. and Mabel L. Criss and Drs. Gilbert and Clinton Beirne Endowed Chair in Nursing at Creighton and a professor of medicine, was the principal investigator for the landmark study. She will also head the new study.<\/p>\n
As with the first study, healthy, postmenopausal women from nine Nebraska counties \u2013 Douglas, Sarpy, Washington, Burt, Colfax, Cuming, Dodge, Saunders, and Butler \u2013 will be selected randomly through phone calls, beginning in April. A study site is being established at the Fremont Area Medical Center, and study visits will be conducted there. A total of 2,300 women will be recruited and followed for four years. Women who participated in the first study are not eligible.<\/p>\n","protected":false},"excerpt":{"rendered":"
The National Institutes of Health has awarded Creighton University $4 million to continue its 2007 landmark study linking vitamin D to a reduction in cancer risk.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1703","post","type-post","status-publish","format-standard","hentry","category-news"],"yoast_head":"\n
TODAY'S HEADLINE STORY: Creighton University to Continue Landmark Study on Vitamin D and Cancer Risk - Smart Tan News<\/title>\n<meta name=\"description\" content=\"The National Institutes of Health has awarded Creighton University $4 million to continue its 2007 landmark study linking vitamin D to a reduction in cancer risk. The study\u2019s findings, reported in June 2007, showed for the first time in a clinical trial that postmenopausal women consuming calcium as well as vitamin D3 supplements at nearly three times U.S. government recommended levels could reduce their risk of cancer by 60-77 percent. The vitamin D3 finding was a secondary goal in the original study,\u201d said Creighton researcher Joan Lappe, Ph.D. \u201cWe must now confirm these findings with a clinical trial specifically designed to look at calcium, vitamin D and cancer. Confirmation is necessary in order to have evidence solid enough to change public policy regarding intake levels for vitamin D.\u201d Most vitamin D researchers are already calling for people to increase their vitamin D levels to 40-60 ng\/ml as measured in blood concentration, recognizing that different intake levels will be necessary for different people to obtain those blood levels. Outdoor workers and non-human primates living in sunny climates, groups who make abundant vitamin D naturally through sun exposure to the skin, already have those levels. Lappe, holder of the Dr. C.C. and Mabel L. Criss and Drs. Gilbert and Clinton Beirne Endowed Chair in Nursing at Creighton and a professor of medicine, was the principal investigator for the landmark study. She will also head the new study. As with the first study, healthy, postmenopausal women from nine Nebraska counties \u2013 Douglas, Sarpy, Washington, Burt, Colfax, Cuming, Dodge, Saunders, and Butler \u2013 will be selected randomly through phone calls, beginning in April. A study site is being established at the Fremont Area Medical Center, and study visits will be conducted there. A total of 2,300 women will be recruited and followed for four years. Women who participated in the first study are not eligible.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TODAY'S HEADLINE STORY: Creighton University to Continue Landmark Study on Vitamin D and Cancer Risk - Smart Tan News\" \/>\n<meta property=\"og:description\" content=\"The National Institutes of Health has awarded Creighton University $4 million to continue its 2007 landmark study linking vitamin D to a reduction in cancer risk. The study\u2019s findings, reported in June 2007, showed for the first time in a clinical trial that postmenopausal women consuming calcium as well as vitamin D3 supplements at nearly three times U.S. government recommended levels could reduce their risk of cancer by 60-77 percent. The vitamin D3 finding was a secondary goal in the original study,\u201d said Creighton researcher Joan Lappe, Ph.D. \u201cWe must now confirm these findings with a clinical trial specifically designed to look at calcium, vitamin D and cancer. Confirmation is necessary in order to have evidence solid enough to change public policy regarding intake levels for vitamin D.\u201d Most vitamin D researchers are already calling for people to increase their vitamin D levels to 40-60 ng\/ml as measured in blood concentration, recognizing that different intake levels will be necessary for different people to obtain those blood levels. Outdoor workers and non-human primates living in sunny climates, groups who make abundant vitamin D naturally through sun exposure to the skin, already have those levels. Lappe, holder of the Dr. C.C. and Mabel L. Criss and Drs. Gilbert and Clinton Beirne Endowed Chair in Nursing at Creighton and a professor of medicine, was the principal investigator for the landmark study. She will also head the new study. As with the first study, healthy, postmenopausal women from nine Nebraska counties \u2013 Douglas, Sarpy, Washington, Burt, Colfax, Cuming, Dodge, Saunders, and Butler \u2013 will be selected randomly through phone calls, beginning in April. A study site is being established at the Fremont Area Medical Center, and study visits will be conducted there. A total of 2,300 women will be recruited and followed for four years. Women who participated in the first study are not eligible.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/\" \/>\n<meta property=\"og:site_name\" content=\"Smart Tan News\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SmartTan\" \/>\n<meta property=\"article:published_time\" content=\"2009-02-16T08:00:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smarttan.com\/blog\/wp-content\/uploads\/2009\/02\/2009-02-16-more-d-research-copy.thumbnail.jpg\" \/>\n<meta name=\"author\" content=\"smarttan\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@SmartTan\" \/>\n<meta name=\"twitter:site\" content=\"@SmartTan\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"smarttan\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/\"},\"author\":{\"name\":\"smarttan\",\"@id\":\"https:\/\/news.smarttan.com\/#\/schema\/person\/4191f4b1131c0a37b4fd39f876771e7b\"},\"headline\":\"TODAY’S HEADLINE STORY: Creighton University to Continue Landmark Study on Vitamin D and Cancer Risk\",\"datePublished\":\"2009-02-16T08:00:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/\"},\"wordCount\":325,\"publisher\":{\"@id\":\"https:\/\/news.smarttan.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/smarttan.com\/blog\/wp-content\/uploads\/2009\/02\/2009-02-16-more-d-research-copy.thumbnail.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/\",\"url\":\"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/\",\"name\":\"TODAY'S HEADLINE STORY: Creighton University to Continue Landmark Study on Vitamin D and Cancer Risk - Smart Tan News\",\"isPartOf\":{\"@id\":\"https:\/\/news.smarttan.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/smarttan.com\/blog\/wp-content\/uploads\/2009\/02\/2009-02-16-more-d-research-copy.thumbnail.jpg\",\"datePublished\":\"2009-02-16T08:00:49+00:00\",\"description\":\"The National Institutes of Health has awarded Creighton University $4 million to continue its 2007 landmark study linking vitamin D to a reduction in cancer risk. The study\u2019s findings, reported in June 2007, showed for the first time in a clinical trial that postmenopausal women consuming calcium as well as vitamin D3 supplements at nearly three times U.S. government recommended levels could reduce their risk of cancer by 60-77 percent. The vitamin D3 finding was a secondary goal in the original study,\u201d said Creighton researcher Joan Lappe, Ph.D. \u201cWe must now confirm these findings with a clinical trial specifically designed to look at calcium, vitamin D and cancer. Confirmation is necessary in order to have evidence solid enough to change public policy regarding intake levels for vitamin D.\u201d Most vitamin D researchers are already calling for people to increase their vitamin D levels to 40-60 ng\/ml as measured in blood concentration, recognizing that different intake levels will be necessary for different people to obtain those blood levels. Outdoor workers and non-human primates living in sunny climates, groups who make abundant vitamin D naturally through sun exposure to the skin, already have those levels. Lappe, holder of the Dr. C.C. and Mabel L. Criss and Drs. Gilbert and Clinton Beirne Endowed Chair in Nursing at Creighton and a professor of medicine, was the principal investigator for the landmark study. She will also head the new study. As with the first study, healthy, postmenopausal women from nine Nebraska counties \u2013 Douglas, Sarpy, Washington, Burt, Colfax, Cuming, Dodge, Saunders, and Butler \u2013 will be selected randomly through phone calls, beginning in April. A study site is being established at the Fremont Area Medical Center, and study visits will be conducted there. A total of 2,300 women will be recruited and followed for four years. Women who participated in the first study are not eligible.\",\"breadcrumb\":{\"@id\":\"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/#primaryimage\",\"url\":\"https:\/\/smarttan.com\/blog\/wp-content\/uploads\/2009\/02\/2009-02-16-more-d-research-copy.thumbnail.jpg\",\"contentUrl\":\"https:\/\/smarttan.com\/blog\/wp-content\/uploads\/2009\/02\/2009-02-16-more-d-research-copy.thumbnail.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/news.smarttan.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TODAY’S HEADLINE STORY: Creighton University to Continue Landmark Study on Vitamin D and Cancer Risk\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/news.smarttan.com\/#website\",\"url\":\"https:\/\/news.smarttan.com\/\",\"name\":\"Smart Tan News\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/news.smarttan.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/news.smarttan.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/news.smarttan.com\/#organization\",\"name\":\"Smart Tan\",\"url\":\"https:\/\/news.smarttan.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/news.smarttan.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/smarttan.com\/news\/wp-content\/uploads\/2022\/08\/Smart-Tan.png\",\"contentUrl\":\"https:\/\/smarttan.com\/news\/wp-content\/uploads\/2022\/08\/Smart-Tan.png\",\"width\":500,\"height\":164,\"caption\":\"Smart Tan\"},\"image\":{\"@id\":\"https:\/\/news.smarttan.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SmartTan\",\"https:\/\/x.com\/SmartTan\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/news.smarttan.com\/#\/schema\/person\/4191f4b1131c0a37b4fd39f876771e7b\",\"name\":\"smarttan\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/60bebff64d4c62315967b9126de927b81d5a9d9511fd52f9dbe9e8b344149182?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/60bebff64d4c62315967b9126de927b81d5a9d9511fd52f9dbe9e8b344149182?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/60bebff64d4c62315967b9126de927b81d5a9d9511fd52f9dbe9e8b344149182?s=96&d=mm&r=g\",\"caption\":\"smarttan\"},\"url\":\"https:\/\/news.smarttan.com\/index.php\/author\/smarttan\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TODAY'S HEADLINE STORY: Creighton University to Continue Landmark Study on Vitamin D and Cancer Risk - Smart Tan News","description":"The National Institutes of Health has awarded Creighton University $4 million to continue its 2007 landmark study linking vitamin D to a reduction in cancer risk. The study\u2019s findings, reported in June 2007, showed for the first time in a clinical trial that postmenopausal women consuming calcium as well as vitamin D3 supplements at nearly three times U.S. government recommended levels could reduce their risk of cancer by 60-77 percent. The vitamin D3 finding was a secondary goal in the original study,\u201d said Creighton researcher Joan Lappe, Ph.D. \u201cWe must now confirm these findings with a clinical trial specifically designed to look at calcium, vitamin D and cancer. Confirmation is necessary in order to have evidence solid enough to change public policy regarding intake levels for vitamin D.\u201d Most vitamin D researchers are already calling for people to increase their vitamin D levels to 40-60 ng\/ml as measured in blood concentration, recognizing that different intake levels will be necessary for different people to obtain those blood levels. Outdoor workers and non-human primates living in sunny climates, groups who make abundant vitamin D naturally through sun exposure to the skin, already have those levels. Lappe, holder of the Dr. C.C. and Mabel L. Criss and Drs. Gilbert and Clinton Beirne Endowed Chair in Nursing at Creighton and a professor of medicine, was the principal investigator for the landmark study. She will also head the new study. As with the first study, healthy, postmenopausal women from nine Nebraska counties \u2013 Douglas, Sarpy, Washington, Burt, Colfax, Cuming, Dodge, Saunders, and Butler \u2013 will be selected randomly through phone calls, beginning in April. A study site is being established at the Fremont Area Medical Center, and study visits will be conducted there. A total of 2,300 women will be recruited and followed for four years. Women who participated in the first study are not eligible.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/","og_locale":"en_US","og_type":"article","og_title":"TODAY'S HEADLINE STORY: Creighton University to Continue Landmark Study on Vitamin D and Cancer Risk - Smart Tan News","og_description":"The National Institutes of Health has awarded Creighton University $4 million to continue its 2007 landmark study linking vitamin D to a reduction in cancer risk. The study\u2019s findings, reported in June 2007, showed for the first time in a clinical trial that postmenopausal women consuming calcium as well as vitamin D3 supplements at nearly three times U.S. government recommended levels could reduce their risk of cancer by 60-77 percent. The vitamin D3 finding was a secondary goal in the original study,\u201d said Creighton researcher Joan Lappe, Ph.D. \u201cWe must now confirm these findings with a clinical trial specifically designed to look at calcium, vitamin D and cancer. Confirmation is necessary in order to have evidence solid enough to change public policy regarding intake levels for vitamin D.\u201d Most vitamin D researchers are already calling for people to increase their vitamin D levels to 40-60 ng\/ml as measured in blood concentration, recognizing that different intake levels will be necessary for different people to obtain those blood levels. Outdoor workers and non-human primates living in sunny climates, groups who make abundant vitamin D naturally through sun exposure to the skin, already have those levels. Lappe, holder of the Dr. C.C. and Mabel L. Criss and Drs. Gilbert and Clinton Beirne Endowed Chair in Nursing at Creighton and a professor of medicine, was the principal investigator for the landmark study. She will also head the new study. As with the first study, healthy, postmenopausal women from nine Nebraska counties \u2013 Douglas, Sarpy, Washington, Burt, Colfax, Cuming, Dodge, Saunders, and Butler \u2013 will be selected randomly through phone calls, beginning in April. A study site is being established at the Fremont Area Medical Center, and study visits will be conducted there. A total of 2,300 women will be recruited and followed for four years. Women who participated in the first study are not eligible.","og_url":"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/","og_site_name":"Smart Tan News","article_publisher":"https:\/\/www.facebook.com\/SmartTan","article_published_time":"2009-02-16T08:00:49+00:00","og_image":[{"url":"https:\/\/smarttan.com\/blog\/wp-content\/uploads\/2009\/02\/2009-02-16-more-d-research-copy.thumbnail.jpg","type":"","width":"","height":""}],"author":"smarttan","twitter_card":"summary_large_image","twitter_creator":"@SmartTan","twitter_site":"@SmartTan","twitter_misc":{"Written by":"smarttan","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/#article","isPartOf":{"@id":"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/"},"author":{"name":"smarttan","@id":"https:\/\/news.smarttan.com\/#\/schema\/person\/4191f4b1131c0a37b4fd39f876771e7b"},"headline":"TODAY’S HEADLINE STORY: Creighton University to Continue Landmark Study on Vitamin D and Cancer Risk","datePublished":"2009-02-16T08:00:49+00:00","mainEntityOfPage":{"@id":"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/"},"wordCount":325,"publisher":{"@id":"https:\/\/news.smarttan.com\/#organization"},"image":{"@id":"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/#primaryimage"},"thumbnailUrl":"https:\/\/smarttan.com\/blog\/wp-content\/uploads\/2009\/02\/2009-02-16-more-d-research-copy.thumbnail.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/","url":"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/","name":"TODAY'S HEADLINE STORY: Creighton University to Continue Landmark Study on Vitamin D and Cancer Risk - Smart Tan News","isPartOf":{"@id":"https:\/\/news.smarttan.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/#primaryimage"},"image":{"@id":"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/#primaryimage"},"thumbnailUrl":"https:\/\/smarttan.com\/blog\/wp-content\/uploads\/2009\/02\/2009-02-16-more-d-research-copy.thumbnail.jpg","datePublished":"2009-02-16T08:00:49+00:00","description":"The National Institutes of Health has awarded Creighton University $4 million to continue its 2007 landmark study linking vitamin D to a reduction in cancer risk. The study\u2019s findings, reported in June 2007, showed for the first time in a clinical trial that postmenopausal women consuming calcium as well as vitamin D3 supplements at nearly three times U.S. government recommended levels could reduce their risk of cancer by 60-77 percent. The vitamin D3 finding was a secondary goal in the original study,\u201d said Creighton researcher Joan Lappe, Ph.D. \u201cWe must now confirm these findings with a clinical trial specifically designed to look at calcium, vitamin D and cancer. Confirmation is necessary in order to have evidence solid enough to change public policy regarding intake levels for vitamin D.\u201d Most vitamin D researchers are already calling for people to increase their vitamin D levels to 40-60 ng\/ml as measured in blood concentration, recognizing that different intake levels will be necessary for different people to obtain those blood levels. Outdoor workers and non-human primates living in sunny climates, groups who make abundant vitamin D naturally through sun exposure to the skin, already have those levels. Lappe, holder of the Dr. C.C. and Mabel L. Criss and Drs. Gilbert and Clinton Beirne Endowed Chair in Nursing at Creighton and a professor of medicine, was the principal investigator for the landmark study. She will also head the new study. As with the first study, healthy, postmenopausal women from nine Nebraska counties \u2013 Douglas, Sarpy, Washington, Burt, Colfax, Cuming, Dodge, Saunders, and Butler \u2013 will be selected randomly through phone calls, beginning in April. A study site is being established at the Fremont Area Medical Center, and study visits will be conducted there. A total of 2,300 women will be recruited and followed for four years. Women who participated in the first study are not eligible.","breadcrumb":{"@id":"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/#primaryimage","url":"https:\/\/smarttan.com\/blog\/wp-content\/uploads\/2009\/02\/2009-02-16-more-d-research-copy.thumbnail.jpg","contentUrl":"https:\/\/smarttan.com\/blog\/wp-content\/uploads\/2009\/02\/2009-02-16-more-d-research-copy.thumbnail.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/news.smarttan.com\/index.php\/todays-headline-story-creighton-university-to-continue-landmark-study-on-vitamin-d-and-cancer-risk\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/news.smarttan.com\/"},{"@type":"ListItem","position":2,"name":"TODAY’S HEADLINE STORY: Creighton University to Continue Landmark Study on Vitamin D and Cancer Risk"}]},{"@type":"WebSite","@id":"https:\/\/news.smarttan.com\/#website","url":"https:\/\/news.smarttan.com\/","name":"Smart Tan News","description":"","publisher":{"@id":"https:\/\/news.smarttan.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/news.smarttan.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/news.smarttan.com\/#organization","name":"Smart Tan","url":"https:\/\/news.smarttan.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/news.smarttan.com\/#\/schema\/logo\/image\/","url":"https:\/\/smarttan.com\/news\/wp-content\/uploads\/2022\/08\/Smart-Tan.png","contentUrl":"https:\/\/smarttan.com\/news\/wp-content\/uploads\/2022\/08\/Smart-Tan.png","width":500,"height":164,"caption":"Smart Tan"},"image":{"@id":"https:\/\/news.smarttan.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SmartTan","https:\/\/x.com\/SmartTan"]},{"@type":"Person","@id":"https:\/\/news.smarttan.com\/#\/schema\/person\/4191f4b1131c0a37b4fd39f876771e7b","name":"smarttan","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/60bebff64d4c62315967b9126de927b81d5a9d9511fd52f9dbe9e8b344149182?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/60bebff64d4c62315967b9126de927b81d5a9d9511fd52f9dbe9e8b344149182?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/60bebff64d4c62315967b9126de927b81d5a9d9511fd52f9dbe9e8b344149182?s=96&d=mm&r=g","caption":"smarttan"},"url":"https:\/\/news.smarttan.com\/index.php\/author\/smarttan\/"}]}},"_links":{"self":[{"href":"https:\/\/news.smarttan.com\/index.php\/wp-json\/wp\/v2\/posts\/1703","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/news.smarttan.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news.smarttan.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news.smarttan.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/news.smarttan.com\/index.php\/wp-json\/wp\/v2\/comments?post=1703"}],"version-history":[{"count":0,"href":"https:\/\/news.smarttan.com\/index.php\/wp-json\/wp\/v2\/posts\/1703\/revisions"}],"wp:attachment":[{"href":"https:\/\/news.smarttan.com\/index.php\/wp-json\/wp\/v2\/media?parent=1703"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news.smarttan.com\/index.php\/wp-json\/wp\/v2\/categories?post=1703"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news.smarttan.com\/index.php\/wp-json\/wp\/v2\/tags?post=1703"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}![\"2009-02-16-more-d-research-copy.jpg\"](\"https:\/\/smarttan.com\/blog\/wp-content\/uploads\/2009\/02\/2009-02-16-more-d-research-copy.jpg\")
<\/a>The study\u2019s findings, reported in June 2007, showed for the first time in a clinical trial that postmenopausal women consuming calcium as well as vitamin D3 supplements at nearly three times U.S. government recommended levels could reduce their risk of cancer by 60-77 percent.<\/p>\n